CapsoVision Inc. (CV) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for CapsoVision Inc., updated every trading day.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus
Price
$7.06
+4.59% today
Market cap
$359M
Overall quality
35/100
Kronos AI 30-day
−1.5%
1 of 8 simulated paths end higher
CapsoVision Inc. (CV) is a Health Care company in Biotechnology: Electromedical & Electrotherapeutic Apparatus, worth $359M. It trades at $7.06, up 4.59% today. Its overall quality score is 35 out of 100, ranked against the whole US market. 1 analysts' average target of $9.00 implies +27.5% from today's price. Kronos AI's 30-day forecast is −1.5% (1 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $9.00 |
| Low – high | $9.00 – $9.00 |
| Analysts | 1 |
| Upside to average | +27.5% |
Kronos AI 30-day forecast
| Expected close | $6.65 (−1.5%) |
| Likely range | −3.7% … −0.0% |
| As of | 2026-10-27 |
1 of 8 simulated paths end higher.
Quality scores
| Profitability | 7 |
| Solvency | 48 |
| Growth | 49 |
| Overall | 35 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Electromedical & Electrotherapeutic Apparatus
For information only, not investment advice. Prices updated: 2026-10-29.